NDC 63629-8697-01 - Nystop
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63629-8697
- Requested NDC
- 63629-8697-01
- Package NDCs from labels
- 63629-8697-1, 63629-8697-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2024-03-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Nystop - Bryant Ranch Prepack | Bryant Ranch Prepack | 2024-03-22 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63629-8697-1 | Nystop | 30 g in 1 BOTTLE, PLASTIC | POWDER | 30 | 105 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63629-8697 | NYSTOP (NYSTATIN) POWDER [BRYANT RANCH PREPACK] | 105 | Current NDC, Legacy NDC, 1 package rows | 20240814_87175864-9877-4e80-b870-907abb8ac289.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63629-8697-1 | GM - Gram | 63629-8697 | e4bc5942-d7fd-44fa-b5dc-622beec6e56d | 1 | 2021-10-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nystatin and Triamcinolone Acetonide | NYSTATIN AND TRIAMCINOLONE ACETONIDE | Torrent Pharmaceuticals Limited | b20217ad-8c25-471a-9f16-9e681b90db05 | 2023-09-14 | Adverse reactions | BDF1O1C72E |
| Nystatin and triamcinolone acetonide | NYSTATIN AND TRIAMCINOLONE ACETONIDE | Macleods Pharmaceuticals Limited | 57c4ebe8-7a8d-4fc0-b6cf-a276b68327fb | 2023-09-07 | Adverse reactions | BDF1O1C72E |
| Nystatin Topical Powder | NYSTATIN TOPICAL POWDER | Epic Pharma, LLC | fb2a480e-0bb1-445e-bbb6-701dea6dc631 | 2023-08-10 | Adverse reactions | 646456 BDF1O1C72E |
| Nystatin | NYSTATIN | Bryant Ranch Prepack | 53d1c23b-9cf2-4941-8701-8a7da1b066cc | 2023-03-03 | Adverse reactions | BDF1O1C72E |
| Nystatin | NYSTATIN | Bryant Ranch Prepack | 84383bc5-1282-43d6-9303-23c8fd8d075f | 2023-03-03 | Adverse reactions | BDF1O1C72E |
| NYSTATIN AND TRIAMCINOLONE ACETONIDE | NYSTATIN, TRIAMCINOLONE ACETONIDE | Padagis Israel Pharmaceuticals Ltd | 92fc188d-4f3e-4d18-aaf1-c9e76b12b75b | 2023-03-01 | Adverse reactions | BDF1O1C72E |
| nystatin and triamcinolone acetonide | NYSTATIN AND TRIAMCINOLONE ACETONIDE | Padagis Israel Pharmaceuticals Ltd | 605540d8-7189-49b9-9e91-572f6b519fae | 2023-03-01 | Adverse reactions | BDF1O1C72E |
| Nystatin | NYSTATIN | A-S Medication Solutions | e069d495-7f1a-4970-8f4d-aa93d124b3fc | 2023-02-04 | Adverse reactions | BDF1O1C72E |
| NYSTATIN | NYSTATIN | Bryant Ranch Prepack | b06c65cd-5b65-4bc6-aae9-b9381c6f1948 | 2023-01-26 | Adverse reactions | BDF1O1C72E |
| Nystatin | NYSTATIN CREAM | Cosette Pharmaceuticals, Inc. | ec1b52af-d38e-eba1-e63c-dba4341d3af2 | 2022-11-22 | Adverse reactions | BDF1O1C72E |
| Nystatin | NYSTATIN CREAM | Proficient Rx LP | b1efcc2c-f71a-463d-9a02-fad7550f31ec | 2022-11-01 | Adverse reactions | BDF1O1C72E |
| Nystatin | NYSTATIN | Teva Pharmaceuticals USA, Inc. | f03b294d-10cd-4bba-92c8-42ae9b110cd0 | 2022-11-01 | Adverse reactions | BDF1O1C72E |
| Nystatin and Triamcinolone Acetonide | NYSTATIN AND TRIAMCINOLONE ACETONIDE | Viona Pharmaceuticals Inc | d3799da3-5923-4225-9c61-2b5af143f555 | 2022-10-08 | Adverse reactions | BDF1O1C72E |
| Nystatin | NYSTATIN | Viona Pharmaceuticals Inc | e135a7d2-adba-48a2-b3e1-07b778cce9b0 | 2022-10-08 | Adverse reactions | BDF1O1C72E |
| Nystatin | NYSTATIN | Proficient Rx LP | d7d04c02-d07d-4382-8f93-5c0c3e68790c | 2022-10-01 | Adverse reactions | BDF1O1C72E |
| Nystatin | NYSTATIN | Proficient Rx LP | e7f0e152-233a-492e-a297-7bf2c543c113 | 2022-05-02 | Adverse reactions | BDF1O1C72E |
| Nystatin | NYSTATIN | Pharmaceutical Associates, Inc. | 31e3da10-5a7b-4bc5-8a4f-3e786b64c13a | 2022-01-13 | Adverse reactions | BDF1O1C72E |
| Nystatin and triamcinolone acetonide | NYSTATIN AND TRIAMCINOLONE ACETONIDE | Macleods Pharmaceuticals Limited | 15bf2ff1-510e-4f0e-9817-8af28790e01b | 2021-09-01 | Adverse reactions | BDF1O1C72E |
| Nystatin | NYSTATIN | Macleods Pharmaceuticals Limited | d8ebb61a-a326-4f0d-a346-c3db045c3fb0 | 2021-08-25 | Adverse reactions | BDF1O1C72E |
| nystatin | NYSTATIN | Proficient Rx LP | 04d795f3-aad7-4b79-8ebc-43c500afe39b | 2021-08-01 | Adverse reactions | BDF1O1C72E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.